当前位置：首页 > 文献互助 > 互助详情

Development of Mid-size Bivalent Inhibitors Targeting a Cancer-related Kinase复制

用户i2224dSSuJrw 1小时前 12 20 已完结

1. 当前求助状态已完结, 请及时下载应助文件

2. 系统将在 2026-01-23 22:51:25 删除文件

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: doi.org/10.1248/yakushi.25-00123 复制

文献链接: https://europepmc.org/article/med/41034106复制

其他信息:

上一篇：GH28 polygalacturonase of human gut Bacteroides spp. confers the degradation of a novel branched galacturonan isolated from Jasminum nudiflorum

下一篇：Neuroblastoma metastatic to the central nervous system: Survival analyses from the German Childhood Cancer Registry and the literature

互助时间线

2026-01-16 22:58:29 [完结求助]

楼主确认了小幸运007应助的文件是正确的, 求助状态变成 已完结

2026-01-16 22:51:25 [上传文件]

小幸运007上传了文件(pdf 4.06 MB), 求助状态变成 待确认

2026-01-16 22:51:13 [发起求助]

最新发布的求助

Neuroblastoma metastatic to the central nervous system: Survival analyses from the German Childhood Cancer Registry and the literature 1小时前
Development of Mid-size Bivalent Inhibitors Targeting a Cancer-related Kinase 1小时前
GH28 polygalacturonase of human gut Bacteroides spp. confers the degradation of a novel branched galacturonan isolated from Jasminum nudiflorum 3小时前
Atomic layer deposition 3小时前
Lensless facial recognition with encrypted optics and a neural network computation 3小时前
S100A12 (EN-RAGE) in monitoring Kawasaki disease 5小时前
The evolving landscape of targets for lipid lowering: from molecular mechanisms to translational implications 5小时前
Targeting trained immunity 6小时前
Long-Term Outcomes in IgA Nephropathy 6小时前
Primary pulmonary NUT midline carcinoma: An elusive and a rare diagnostic entity 7小时前
Current and future of targeted therapies against BCR:: ABL kinases 7小时前
Nedosiran, a Candidate siRNA Drug for the Treatment of Primary Hyperoxaluria: Design, Development, and Clinical Studies 7小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com